Emergency coronary bypass for cardiogenic shock

R A Guyton1, J M Arcidi, D A Langford

  • 1Department of Medicine, Carlyle Fraser Heart Center, Crawford W. Long Memorial Hospital, Emory University School of Medicine, Atlanta, GA.

Circulation
|November 1, 1987
PubMed

Insights

Emergency coronary artery bypass surgery for cardiogenic shock shows improved survival rates. This study found a 12% in-hospital mortality for shock patients, with 88% surviving three years post-operation.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Critical Care Medicine

Background:

  • Emergency coronary artery bypass (CAB) for cardiogenic shock traditionally carries high operative mortality.
  • Patient management and outcomes in this high-risk group require further investigation.

Purpose of the Study:

  • To evaluate the outcomes of emergency coronary artery bypass surgery in patients with and without cardiogenic shock.
  • To compare complication rates, mortality, and long-term survival between the two groups.

Main Methods:

  • Retrospective analysis of 69 patients undergoing emergency CAB from January 1983 to March 1986.
  • Patients were divided into two groups: those in cardiogenic shock (n=17) and those without shock (n=52).
  • Data collected included demographics, preoperative condition, intraoperative support, postoperative complications, mortality, and long-term follow-up.

Main Results:

  • The cardiogenic shock group had a 12% in-hospital mortality compared to 2% in the non-shock group (p < .05).
  • Postoperatively, 94% of shock patients required catecholamines and 71% needed intra-aortic balloon pump support, significantly higher than the non-shock group (p < .05).
  • Three-year survival was 88% +/- 8% for the shock group and 91% +/- 4% for the non-shock group. Major complications occurred in 47% of the shock group versus 13% in the non-shock group (p < .05).

Conclusions:

  • Emergency coronary artery bypass surgery in patients with cardiogenic shock, while associated with higher mortality and complication rates, can achieve acceptable long-term survival.
  • Careful patient selection and perioperative management are crucial for improving outcomes in this high-risk population.
  • The study highlights significant differences in resource utilization and complications between shock and non-shock patients undergoing emergency CAB.

Related Concept Videos

Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...